Dthera Sciences announced the appointment of Amir Kalali, M.D. to its Board of Directors. Dr. Kalali will also be Chairman of Dthera's Scientific Advisory Board. Both positions are effective October 30, 2018. Previously, Dr. Kalali was the Global Head of the Neuroscience Center of Excellence at Quintiles, now known as IQVIA. He is Clinical Professor of Psychiatry at the University of California San Diego, Editor of the journal Innovations in Clinical Neuroscience, and the Lead Editor of the book Essential CNS Drug Development.